Century Therapeutics, Inc. — Director's Dealing 2024

Dec 6, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Century Therapeutics, Inc. (IPSC)
CIK: 0001850119
Period of Report: 2024-12-04

Reporting Person: Pfeiffenberger Brent (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-12-04	Common Stock	F	243447	$1.44	Disposed	1227257	Direct

Footnotes

F1: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.